Mednet Logo
HomeNeurologyQuestion

Which novel immunomodulatory treatment(s) do you consider in refractory seronegative bulbar-predominant myasthenia?

1 Answers
Mednet Member
Mednet Member
Neurology · University of Minnesota
  1. Re-evaluate the diagnosis. Acetylcholine receptor and MuSK antibody-negative myasthenia with prominent bulbar symptoms, refractory to all the agents mentioned (steroids, MMF, AZA, IVIG) is an extremely rare scenario. Differential diagnosis includes bulbar onset ALS and numerous myopathies (e.g. IBM...

Register or Sign In to see full answer